197 related articles for article (PubMed ID: 7955203)
1. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.
Wollert KC; Studer R; von Bülow B; Drexler H
Circulation; 1994 Nov; 90(5):2457-67. PubMed ID: 7955203
[TBL] [Abstract][Full Text] [Related]
2. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
[TBL] [Abstract][Full Text] [Related]
3. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
[TBL] [Abstract][Full Text] [Related]
4. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor binding following myocardial infarction in the rat.
Sun Y; Weber KT
Cardiovasc Res; 1994 Nov; 28(11):1623-8. PubMed ID: 7842454
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
Luo JD; Zhang WW; Zhang GP; Guan JX; Chen X
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812
[TBL] [Abstract][Full Text] [Related]
10. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
11. Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats.
Nomoto T; Nishina T; Tsuneyoshi H; Miwa S; Nishimura K; Komeda M
J Card Surg; 2003; 18 Suppl 2():S61-8. PubMed ID: 12930272
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats.
Nomoto T; Nishina T; Miwa S; Tsuneyoshi H; Maruyama I; Nishimura K; Komeda M
Circulation; 2002 Sep; 106(12 Suppl 1):I115-9. PubMed ID: 12354719
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
Sharp S; Poglitsch M; Zilla P; Davies NH; Sturrock ED
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657
[TBL] [Abstract][Full Text] [Related]
14. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
15. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
Goa KL; Balfour JA; Zuanetti G
Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.
Marie C; Mossiat C; Gros C; Schwartz JC; Lecomte JM; Bralet J
Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026
[TBL] [Abstract][Full Text] [Related]
17. Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?
Sugie T; Kagaya Y; Takeda M; Yahagi H; Takahashi C; Takahashi J; Ninomiya M; Watanabe J; Ichinohasama R; Tezuka F; Shirato K
Cardiovasc Res; 2003 Jun; 58(3):611-20. PubMed ID: 12798434
[TBL] [Abstract][Full Text] [Related]
18. Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output heart failure.
Nishimura H; Oka T; Ueyama M; Kubota J; Kawamura K
J Cardiovasc Pharmacol; 1994 Jan; 23(1):149-54. PubMed ID: 7511728
[TBL] [Abstract][Full Text] [Related]
19. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
20. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction.
Schieffer B; Wollert KC; Berchtold M; Saal K; Schieffer E; Hornig B; Riede UN; Drexler H
Am J Physiol; 1995 Nov; 269(5 Pt 2):H1507-13. PubMed ID: 7503242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
